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ABSTRACT
Tick – borne relapsing fever (TBRF) is globally dispersed, and within the United States is
found primarily in the mid – west, south - west, and north – west portions of the country.
TBRF is a disease which causes patients to experience flu – like symptoms and is
distinguished by multiple relapses of high fever which can cause individuals to be
hospitalized multiple times over months. TBRF is caused by Borrelia spp. spirochetes
and spread by Onthidoros spp. soft – shelled ticks. First diagnosed in the early 20th
century, the disease has gone underdiagnosed and has attracted little attention for over a
century despite being the cause of illness in multiple outbreaks. Previous reviews on the
subject have been limited in scope and focused on state – specific reports in localized
regions of the country. The primary and secondary objectives of our review were to
describe the epidemiology, scope, and clinical outcomes of TBRF to update the medical
community on its impact and also to establish an evidence - based reasoning for inclusion
of TBRF in the NNDSS. We present our review of TBRF as the most expansive in regard
to years covered and sample size. As well, this is the only review, to our knowledge,
which has collected and analyzed data by infection type. Papers selected for review had
to be original case reports of TBRF infections, published in English, and have occurred in
the United States. Data from similar reviews were not included nor were those papers
used for analysis. Added criteria were used to collect data on cases which could be used
for logistic and Poisson regressions analyzing the likelihood of clinical outcomes. After
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the review process was complete, 80 papers were used for the primary analysis and 40
papers used to collect data for regression analyses. Results showed that most of TBRF
infections took place in adults and children. Men were statistically more likely to be
infected than women (p= <0.0001). Symptom profiles for causative agents confirmed flulike symptoms as the most reported (headaches, vomiting, chills/sweats) but revealed that
many symptoms were statistically more likely to be found in B. turicatae infections
compared to B. hermsii infections, indicating that infection type influences clinical
presentation of the disease. Modeling febrile episodes and Jarisch – Herxheimer reactions
on treatment type hinted that some treatments are better than others but no statistically
significant claims can be drawn from this analysis. In conclusion, this review highlights
important differences between our results and prior published literature reviews, as well
as provides recommendations on reporting practices, treatment protocols, and future work
while arguing that TBRF should be a nationally notifiable disease and reported to the
NNDSS.
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CHAPTER 1
INTRODUCTION
The National Notifiable Diseases Surveillance System (NNDSS) is a network of systems
run by the United States Centers for Disease Control (CDC) and Prevention which works
on a national level to compile data on disease incidence, distribution, disease agents, and
host factors. The NNDSS works in conjunction with the Council of State and Territorial
Epidemiologists (CSTE), whose job it is to provide a recommended list of nationally
notifiable diseases and coordinate with state and local health departments and health
agencies, which provide case data for informing periodical updates to the list of
nationally notifiable diseases.1
Disease reporting begins on the state and local level with cases identified by
health providers, hospitals, and laboratories. State legislatures, on recommendation from
health agencies and health professionals, dictate which diseases are mandatorily reported
allowing for state funds to be utilized accordingly.2 There are many diseases which are
universally reported, such as salmonella outbreaks and highly contagious vaccinepreventable infectious diseases. Other diseases, which are found regionally, are
sporadically reported depending on the incidence of disease. Because there are no federal
laws which dictate disease reporting, conveying information to the CDC on the federal
level is technically voluntary. Despite being non-compulsory, every U.S. state health
department, five territorial health departments, and two local health departments (New
York City and D.C.) report to the CDC for diseases which are nationally
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notifiable.3 Diseases on the nationally notifiable list are those of particular concern for
public health, thus justifying allocation of state tax revenue and health department
resources for tackling of these priority conditions. This criterion includes emerging
pathogens or any other disease which is deemed a large enough health concern. If
properly addressed, the incidence of these diseases and health hazards are reduced, and if
at some point the incidence is reduced enough or its surveillance is not seen as justifiably
beneficial, a disease may be taken off the notifiable list. Some of the benefits of having a
disease on the nationally notifiable list is that it receives more exposure to the health
community and local resources, making identification and treatment easier and more
efficient. Further, it helps establish and/or create a federal database on all reported cases
in the United States.4–6 Additionally, the infrastructure created by surveillance reporting
laws ensures the maintenance of strong working relationships between physicians and
public health entities that are critical for effective infectious disease outbreak response.7
Centralized and formatted data is incredibly useful for conducting research on diseases
and coming up with strategies to prevent further incidence. One of the diseases not
currently on the nationally notifiable list is Tick – borne Relapsing Fever (TBRF).
Relapsing fever is a global vector-borne disease caused by infection with Borrelia
spp. spirochetes. Louse and tick – borne relapsing fevers are epidemic and endemic,
respectively.8,9 While the primary foci of louse-borne relapsing fever is east Africa, a
true understanding of TBRF is less known yet of public health importance, and early
identification of endemic areas can prevent future outbreaks.10,11 Global estimates of
TBRF are lacking, but the disease has been reported in Africa, Asia, Europe, and North
America.12 In Asia, specifically in Japan, various Ixodes ticks are responsible for
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infection with Borriella miyamatoi spirochetes,13 whereas in Africa, several Ornthidoros
spp. soft ticks, such as Ornthidoros moubata, transmit Borrelia duttoni, B. crocidurae,
and B. hispanica.12,14 Our understanding of endemic TBRF in the United States is still in
its infancy with only two major reviews done on the disease, both published in the last 15
years.15,16
In the United States, TBRF is most commonly found in the south-west, mid-west,
and pacific north-west, with California and Colorado being the biggest contributors to
disease incidence.16 TBRF, as the name suggests, is a disease which causes intermittent
febrile episodes and is contracted after a tick vector has taken a blood meal from a human
host. Those infected can expect, on average, to experience two to four febrile episodes
with fevers ranging from 103 degrees to 108 degrees Fahrenheit. Pregnant women are
particularly vulnerable to TBRF and can experience spontaneous miscarriage, hepatic
involvement, neonatal asphyxia, preterm delivery, and death. Transmission of the
spirochete from mother to infant can occur prenatally via the placenta or during labor and
birth.17 Less serious complications caused by TBRF include chills/sweats, nausea,
malaise, and headaches. Standard treatment varies from single to multiple rounds of
antibiotics including tetracycline, doxycycline, and macrolides (e.g. erythromycin).
Patients treated with antibiotics for TBRF have a 50% chance of experiencing a Jarisch –
Herxheimer reaction where their symptoms worsen along with rigors, hypotension, and
high fever.15 TBRF has been treated with many different types of antibiotics in the past
and present, most likely due to the lack of treatment guidelines for TBRF which would
standardize treatment protocols for the disease.18
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The causative agents of TBRF are bacterial spirochetes of the genus Borrelia and
species in the United States are B. hermsii, and B. turicatae. Similar to other spirochetes,
B. hermsii and B. turicatae bacteria manipulate surface antigens to avoid detection from
host defenses.18–20 This ability to change surface proteins lets them hide out in hosts and
cause bouts of high-grade fever when proliferation of the bacteria becomes high enough.
The spirochete (corkscrew) shaped bacteria are problematic for diagnosis using
microscopy because their shape is similar to other bacteria such as Helicobacter, for
example.18 Serological testing also presents some challenges because false positives on
tests for Lyme disease are common due to the similarity of proteins between the Borrelia
spp.21–23 Knowing the geographic region the patient was exposed along with other
contextual pieces of clinical and epidemiological information is important for proper
identification, diagnosis, and treatment.
The ticks which bear these bacteria are argasid (soft-bodied) ticks of the genus
Ornithodoros. In the United States, the bacteria species are named for the tick which
bears them. O. hermsi ticks are typically found in high elevation areas (>5000ft) along
the Western US mountain ranges whereas O. turicata ticks are found in low elevation
areas such as Texas, Florida, and Nevada.16 Sylvatic transmission occurs during
bloodmeal feeding between ticks and reservoir species, primarily squirrels, chipmunks,
and other rodents. Humans are not typical reservoir hosts but can be infected and serve as
competent mammalian reservoirs if bloodmeals are taken during the febrile bacteremia
period. Spirochetes are transmitted via tick saliva, and once in the human blood stream
they begin to proliferate in the human host causing disease.24 Vector characteristics play
an important role in transmission. To illustrate this, compare the differences between
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Ixodidae (hard) and Argasidae (soft) bodied ticks. Besides having different physical
appearances, the ticks also have different life cycles and feeding strategies.25 Hard ticks
have only three life stages, a larval stage, a nymphal stage, and an adult stage whereas
soft ticks have several nymphal stages as well as the larval and adult stage. The increased
number of nymphal stages translates to greater pathogen transmission opportunities as
soft ticks require bloodmeal to complete each molting.26 Hard ticks seek out prey and are
active during daylight and nighttime hours while soft ticks lie in wait for their prey and
are primarily nocturnal. Lastly, feeding time for hard ticks is much longer (hours to
weeks) than soft ticks (15 – 90 minutes).25
Hard ticks are responsible for transmitting Lyme disease, Rocky Mountain
spotted fever, tularemia, Colorado tick fever, etc. while soft ticks are known only to
transmit TBRF.27,28 This may be in part to the types of hosts the ticks feed on and the
ubiquity with which hard ticks are found allowing them to come into contact with a larger
variety of species. Their predator habits, seeking out their prey, add to this fact but also
show why people are more likely to come into contact with hard ticks. Soft ticks come
into contact with human hosts most commonly in remote caves, cabins, or camping sites,
and because they feed at night, they are less active than hard ticks.
While hard ticks are responsible for most of the disease burden caused by tick
species, however, there are two characteristics of soft ticks which makes them especially
worth considering as a public health issue. Unlike the hard tick which can only transmit
the spirochete bacteria during its adult life state, soft ticks can pass on the bacteria
throughout all nymphal stages as well as their adult stage. While more limited in activity
than hard ticks, they are more dangerous over their lifespans respectively because they
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can transmit the bacteria earlier than hard ticks and for a longer period of time. Soft ticks
not only feed for a shorter period of time, their time to transmit the bacteria is also much
shorter than the hard ticks. Soft ticks have been shown to transmit spirochetes within 30
seconds, much less than the hours it takes a hard tick to transmit a pathogen like the one
that causes Lyme disease.29 If a person is bitten by a tick which carries B. burgdorfi, there
is a good chance that individual will not be infected as long as they notice the tick
feeding within an hour or two.30 Yet, if an individual is fed on by an O. hemsi tick, the
time it takes to notice the tick feeding is almost inconsequential as it is likely long passed
the time necessary to transmit the bacteria. Lastly, Ornithodoros spp. ticks can live up to
10-20 years and go years without a bloodmeal source, which is significantly longer on
both accords than its hard tick comparator.
TBRF is often overshadowed by other louse/tick borne infections because it
accounts for less of the disease burden in this category than other diseases. Between 1990
and 2011 there were only 504 cases of TBRF reported to state and local agencies.16 For
comparison, over 30,000 cases of Lyme disease are reported to the CDC every year with
estimates that the true burden of disease is between 296,000–376,000 cases/year.31,32 But
incidence alone does not tell the whole story. Because there is no national reporting
recommendation for TBRF, it is likely that the amount of cases reported is much lower
than the actual burden. Difficulty in identifying the causative agent with microscopy and
laboratory techniques might also be a contributing factor to underreporting. Those who
become infected by TBRF experience reoccurring episodes of debilitating fevers,
headaches, and pains. In more extreme cases TBRF can cause death, especially in
childbearing mothers and neonatal infants. Overall disease burden might not be high, but
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morbidity associated with TBRF is extreme. TBRF is an easily acquired, dangerous
infection which requires more attention. Making TBRF a nationally notifiable condition,
along with constructing standardized treatment guidelines will help prevent future cases
of the disease, decrease mortality, and mitigate morbidity.
Despite a suspected knowledge gap among United States physicians, cases have
been consistently reported since 1922.9,15 The primary goal of this historical review is to
inform the medical community of TBRF clinical characteristics and epidemiologic
associations in an effort to identify areas of high disease burden and enhance differential
diagnosis of high-risk populations. We theorize that the lack of notifiable disease status
has resulted in low knowledge among healthcare providers possibly translating to an
underdiagnosis of these important pathogens. The secondary aim is to compare the
Borrelia species responsible for TBRF to identify potential differences in infection
prevalence, clinical manifestation of disease, transmission of risk factors, risk of JarischHerxheimer reaction and mortality rate. The last aim of this paper is to use the
information gathered in the systematic review to determine a potential need, rational and
justification for inclusion of TBRF on the national notifiable list.
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CHAPTER 2
METHODS
A systematic review was conducted in compliance with Preferred reporting items for
systematic reviews and meta-analyses (PRISMA).33 Our initial literature search was
conducted utilizing Medline and PubMed using the following search terms: tick borne
relapsing fever, Borrelia turicatae, Ornithodoros turicata, Borrelia hermsii,
Ornithodoros hermsi, and United States. Ornthidoros parkeri and Borrelia parkerii were
excluded from this review, as they were only added to the list of TBRF causative agents
within the last three years and would not have adequate representation in our historical
review. In an effort to include all historical manuscripts that might not be included in
current electronic format, a second trace-back search of included manuscripts’ reference
lists was also conducted. Manuscripts were excluded if transmission was suspected
outside the geographic United States, not published in English, or if the article was not
clinical or human health related. In order to gather sufficient sample sizes and maintain
data quality, information from each article was screened on the basis of each variable. If a
paper included an appropriate amount of data concerning method or place of infection,
duration of sickness, and risk factors then it was included in the analysis. For example, if
a paper reported infections on 100 patients but only had symptom data for two then only
the symptom data for those two cases would be analyzed while the other 98 would be
discounted from inclusion in a denominator on symptom frequency so as to avoid zero
inflation. However, those other 98 cases could still be used in geospatial clustering. The
8

guiding principle in this exercise was to make sure that the total number for the article
had corresponding, matching data on the variable which statistics were gathered on. The
second literature collection, a sub grouping of the original, was gathered in order to
perform a regression analyses on two clinical outcomes as well as descriptive statistics on
infection characteristics. The added criteria for inclusion in this collection required that
the data be matched to a particular ID. Whereas the larger dataset included aggregate and
specific data, the smaller dataset only included data which had matching participants. To
be matching, data on prognosis, symptoms, treatment, and risk factors must be related to
an identified patient with information on age and sex available.
Information extracted from each article included clinical history and presenting
illness, clinical laboratory values, diagnostic test used, patient prognosis and course of
illness, and epidemiologic risk factors. Descriptive statistics summarized each of these
categories’ variables. Chi-squared tests were used to test for independence between
proportions of individuals with B. hermsii or B. turicatae infections on the basis of sex,
age, and symptom frequency. In instances with small frequency counts (≤5), Fisher’s
exact test was used in place of a Chi-squared test. Disease prognosis by infection type,
including average incubation days, average febrile and afebrile days, and average number
of febrile episodes was analyzed via a T-test under normal theory assumptions. In
addition to these analyses, a multivariable logistic model was used to estimate the risk of
a Jarisch – Herxheimer reaction using treatment comparisons as the predictor of interest
with standard statistical assumptions. Poisson regression was used to analyze the
association between number of febrile episodes and treatment type and other standard
predictors. Other covariates for both regressions were sex and age. All statistical analyses
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were performed using SAS 9.4 software (SAS Institute Inc., Cary, North Carolina).
Finally, geospatial cluster analysis was performed on cumulative clinical records by
location to identify hotspots for disease incidence, using ArcGIS Pro v.2 (ESRI
Corporation, Redlands, CA).
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CHAPTER 3
RESULTS
The original literature search and subsequent search done by reviewing sources included
in the first search yielded 190 articles. After screening by titles and abstracts, three were
found to contain duplicate data and removed from the review. 187 articles were screened
through full text and 111 were excluded leaving 76 papers for the primary analysis. Of
those 76, 40 met the requirements for inclusion in the secondary analysis and were
included therein (Figure 3.1).

Primary Analysis Findings
The total number of cases included was 1241 (B. hermsii = 493 | B. turicatae = 748),
ranging in years from 1915 to 2016. Both B. hermsii and B. turicatae infections occurred
primarily in adults and children. Combining both age categories, adults and children
accounted for 95% of B. hermsii infections and 99% B. turicatae infections. Age data
was analyzed categorically. Four discrete age groups were constructed (adult ≥ 18 years,
pediatric 1 – 17 years, infant < 1 year, elderly ≥ 60 years). There were no significant
differences in the proportion of infections comparing all age groups (p=0.4288), nor were
there significant differences in proportions of infections comparing adults to children
(p=0.3363), adults to infants (p=0.3239), or adults to elderly (p=0.6762). The percentage
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of males with B. hermsii or B. turicatae infections was significantly higher (p= <0.0001)
than females (Table 3.1).
Aggregated symptom data was available for 433 patients (B. hermsii = 391 | B.
turicatae = 42). Fever, chills/sweats, headache, nausea, vomiting, myalgia, weakness, and
malaise were the most reported symptoms among both infections combined, with each
being reported 18% – 77% of the time. Clinical symptoms were recorded dichotomously,
even if symptoms reoccurred during multiple relapses. Symptoms indicative of serious
complications, including splenic enlargement and tachycardia were reported for
combined infections 13% and 8% of the time. Other serious complications, including
tachypnea, jaundice, hypoxia and syncope were reported less than 5% of the time. There
were statistically significant differences between infection types for most of the
symptoms (symptoms reported >5% of the time). Compared to B. hermsii, those infected
with B. turicatae were more likely to report fever (p=0.0012), headache (p=0.0007),
nausea (<0.0001), vomiting (p=0.0004), myalgia (p=0.0365), weakness (p=0.0004),
arthralgia (p=0.0012), malaise (p=<0.0001), rash (p=<0.0001), tachycardia (p=<0.0001),
and back pain (p=<0.0001) (Table 3.2). Conversely, B. hermsii patients were more likely
to present with anorexia (p=0.0071) than B. turicatae patients.
Aggregated data for other prognostic indicators including incubation period,
febrile days (how many days total experiencing fever), afebrile days (how many days
total without fever between febrile periods), and total febrile episodes (instance of a
febrile period or episode) was collected for 929 patients. Overall, the average amount of
incubation days was 8, with a range from 1 – 25 days. Patients experienced an average of
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4 febrile days and 4 febrile periods and 7 afebrile days. No significant differences
between infection types were noted for each of these variables (Table 3.3).
Published reports on year of incidence was available for 1241 patients. The
primary dataset found that most case data were for infections which occurred in the early
to mid – 20th century, specifically in the 1930s and 1960s. Some of that data that was
collected was on a range of years. For those infections the midpoint in the range of years
was selected as year of infection (Figure 3.2). Data on month when infection occurred
was collected for 1485 patients. Most cases take place in the summer months and trails
off in the fall and winter while gradually increasing through the spring. The months of
June, July, and August are roughly responsible for a combined 60% of the total incidence
observed in the study (Figure 3.3). Incidence by state where infection was either
confirmed or suspected to have occurred was included for 1110 people in 14 states. Over
50% of these cases took place in Texas which means that the causative agent in these
TBRF infections was most likely B. turicatae. This is in contrast to recent literature
which typically sties cases in California and Colorado as having the highest incidence for
TBRF. California and Colorado were the next highest states for TBRF infections, besides
Arizona, with 619 and 63 cases each, respectively. A single case was noted in Ohio, far
from the endemic areas where Ornthidoros spp. ticks are typically found (Figure 3.4).

Secondary Analysis Findings
The following are the findings presented from the case files with matching data. The total
number of cases included in this analysis was 67 (B. hermsii = 51 | B. turicatae = 16)
with data on cases from 1961 to 2016. Characteristics of infection were recorded for all
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67 cases. Only 25% of patients reported observing a tick bite and evidence of tick
infestation was found in only 22% of cases. Most infections occurred in either cabins
(34%), caves (17%), and the general outdoors (8%). Borellia positive ticks and Borellia
positive reservoir animals were located at the site of infection 18% and 13% of the time,
respectively. In almost half of all cases (41%), the sleeping structure where infection
occurred was uninhabited at times, often for months (Table 3.4).
Using case specific data collected in the secondary analysis, two regressions were
generated to describe possible relationships between treatment type and either risk of
Jarisch – Herxheimer reactions or number of febrile episodes. The first outcome was
analyzed using a logistic regression with age and sex as co-predictors along with
treatment type. In current literature, tetracycline is often cited as the preferred treatment
for TBRF, thus in our analysis tetracycline was used as the referent group comparing
doxycycline, penicillin, or combination/other treatments. Odds ratios show that penicillin
and combination/other treatment was less likely (OR = 0.90 and 0.66, respectively) than
tetracycline alone to result in a Jarisch – Herxheimer reaction. However, doxycycline was
2.56 times as likely to result in a Jarisch – Herxheimer reaction than tetracycline (Table
3.5).
To evaluate the association between treatment type and number of febrile
episodes, a Poisson regression was used. Compared to tetracycline treatment, the
incidence rate ratios for number of febrile episodes were 1.24, 1.11, and 0.79 for
combination/other, doxycycline, and penicillin, respectively. This means that the incident
rate of febrile episodes for combination/other treatment was 1.24 times the incident rate
of the same outcome for tetracycline treatment, meaning that only penicillin resulted in a
14

lower incident rate of febrile episodes compared to tetracycline use (Table 3.6). Note that
the results of the logistic and Poisson regressions are not statistically significant, as the
inferences associated with the outputs have wide confidence intervals that include one,
indicating the possibility that there were no differences in either measured outcome based
on treatment type.
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Figure 3.1 Flowchart displaying search process and
record selection for analysis.
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Table 3.1 Demographic characteristics of TBRF cases.
Variable

B. hermsii (N=308)

B. turicatae (N=100)

Age (%)

p-value
0.4288

Adult (18-60)

126 (56)

55 (65)

Pediatric (1-17)

86 (39)

29 (34)

Infant (<1 yr)

5 (2)

0 (0)

Elderly (60+yrs)

6 (3)

1 (1)

Sex (%)

<.0001

Male

194 (63)

259 (87)

Female

114 (37)

40 (13)

Note. Adult (18-60), Pediatric (1-17), Infant (<1yr), Elderly (60yrs+)
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Table 3.2 Symptom profile of TBRF cases.
Symptom
Overall N (%) B. hermsii n (%) B. turicatae n (%)
N = 433
n = 391
n = 42
Fever
337 (77)
296 (76)
41 (98)
Chills/Sweats
212 (50)
193 (49)
25 (60)
Headache
223 (53)
200 (51)
33 (79)
Nausea
148 (35)
122 (31)
26 (62)
Vomiting
132 (32)
118 (30)
24 (57)
Myalgia
202 (48)
185 (47)
27 (64)
Weakness
93 (22)
75 (19)
18 (43)
Arthralgia
46 (11)
43 (11)
12 (29)
Anorexia
69 (16)
67 (17)
1 (2)
Malaise
78 (18)
55 (14)
23 (55)
Abdominal Pain
44 (10)
51 (13)
0 (0)
Rash
42 (10)
21 (5)
23 (55)
Splenic Enlargement
57 (13)
50 (13)
7 (17)
Tachycardia
35 (8)
21 (5)
14 (33)
Eye pain
34 (8)
34 (9)
0 (0)
Back pain
33 (8)
8 (2)
25 (60)
Red eyes
33 (8)
33 (8)
0 (0)
Diarrhea
26 (6)
26 (7)
0 (0)
Note. Rest of symptoms including blurred vision, congestion, confusion,
dehydration, dizziness, dyspnea, epigastric pain, fatigue, hypotension,
hypoxia, jaundice, lethargy, leg pain, meningitis (suspected), photophobia,
retrobulbar pain, rhinorrhea, sore throat, syncope, tachypnea, and weight
loss each accounted for ≤ 5% of symptom occurrence.
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p-value
0.0012
0.2106
0.0007
<0.0001
0.0004
0.0365
0.0004
0.0012
0.0071
<0.0001
NA
<0.0001
0.4799
<0.0001
NA
<0.0001
NA
NA

Table 3.3 Prognostic indicators of RF by causative agent.
Overall avg. (range)
Incubation
Days
Febrile
Days
Afebrile
Days
Febrile
Episodes

9 (1-25)

B. hermsii avg.
(range)
8 (1-15)

B. turicatae avg.
(range)
10 (6-25)

pvalue
0.588

4 (1-17)

4 (1-17)

4 (1-9)

0.978

7 (1-20)

7 (1-20)

8 (5-10)

0.446

3 (1-15)

3 (1-8)

5 (2-15)

0.204

# of cases over decades
275
250
225
200

# of cases

175
150
125
100
75
50
25
0
1900
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Figure 3.2 Incidence of infections described over the decades.
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Figure 3.3 Incidence of infections by month.

Figure 3.4 Shaded map of confirmed or suspected TBRF
cases identified in the final analysis.
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Table 3.4 Characteristics of infection.
Characteristic
Patient reported tick bite
Cabin associated
Trailer Associated
Camping Associated
Evidence of tick infestation
Ticks recovered from site
Cave site
Condominium
General outdoors
B+ ticks found at site
B+ animals found at site
Pregnancy associated
Sleeping structure uninhabited at times

% cases reported
25%
34%
1%
4%
22%
21%
17%
4%
8%
18%
13%
5%
41%
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Table 3.5 Results of logistic regression modeling Jarisch - Herxheimer reaction and
treatment comparison.
Treatment Comparison
Estimate
OR (95% CI)
Combination/other vs. Tetracycline
-0.5218
0.66 (0.048 – 9.03)
Doxycycline vs. Tetracycline
0.8387
2.56 (0.173 – 38.4)
Penicillin vs. Tetracycline
-0.2096
0.90 (0.044 – 18.5)
Note. Confidence intervals calculated with alpha at 0.05.

Table 3.6 Results of Poisson logistic regression modeling number of febrile episodes
and treatment type.
Treatment
Estimate
IRR (95% CI)
Combination/other
0.212
1.237 (0.736 – 2.076)
Doxycycline
0.111
1.117 (0.574 – 2.175)
Penicillin
-0.239
0.788 (0.358 – 1.735)
Note. Confidence intervals calculated with alpha at 0.05. Treatment tetracycline used
as referent group.
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CHAPTER 4
DISCUSSION
This review reports on TBRF clinical epidemiology based upon published reports
spreading over a century cumulating 1200 cases originating from 14 states. The
methodology of this report, unlike similar published reviews which use state reported
data, uses previously published cases. This methodological difference can result in less
precise measurements but one of the advantages of our approach is an increased amount
of information over more years which shows not only a current report on the state of the
disease but also a historical perspective. Our data collection method also resulted in
unique variables which have not been previously described and provides a basis for
advanced statistical models which can be used to describe disease presentation and
duration.
Currently, this is the only review at present knowledge which has looked through
case reports and generated this type of data. Data from the CDC is limited and most of
the clinical information is abstracted from a single report by Dworkin et.al.34 To our
knowledge, our sample size represents the largest of its kind and most geographically
represented as well. In the Dworkin et.al paper used by the CDC, information was
gathered on only 4 different states, limited to the most north-west part of the United
States. Given its geographical niche, it is reasonable to infer that this data might be
limited to B. hermsii infections only which might describe some differences in findings.
Clinical presentation of the disease is presented as a single entity, but our review has
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showed differences in clinical presentation based on infection type. Symptom frequency
found in our review is similar to CDC reported data.18 Specific frequency percentages of
symptoms vary marginally but the relative frequencies are identical (i.e. the same
symptoms present the most frequently in our review and previous work, such as
headaches, myalgia, and chills being reported most often). In our analysis, which
contained clinical information on 337 patients, B. turicatae infections were found to have
significantly higher incidences of fever, headache, nausea, emesis, weakness, and more
symptoms despite being much less representative in our sample. This suggests quite
possibly that B. turicatae infections clinically manifest differently from B. hermsii
infections and that treatment and symptom management practices for each disease should
be approached separately instead of how they are currently treated as one.
Profiling this disease is challenging due to the wide array of symptomology and
clinical presentation. The pathogen was found in individuals without fever, suggesting
that infections can occur which do not cause fever but still cause other flu-like symptoms.
Those asymptomatic infections noted in our review were identified in outbreak
investigations, suggesting that all persons with exposures should be tested for infection.
While the majority of cases did report fever and flu-like illness described above,
symptoms were not consistently grouped together between patient populations or within
the individual patient. Within a single individual, different febrile relapse episodes could
be accompanied by a multitude of other symptoms and rarely were they consistent. While
febrile episodes typically lessened in duration after the initial episode, this was not
always true. At present, this review, nor any other articles have been able to identify
clinically reproducible trends as this disease runs its course. One of the main indicators of
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TBRF, besides relapsing episodes, is fever temperature which averaged over 103 degrees
Fahrenheit. From data collected it was not possible to determine a statistical relationship
between the number of febrile relapses and temperature. Because temperature was
typically recorded for only the first febrile episode, there was not enough data to make
any inference on whether temperature wanes or increases with repeated febrile relapses.
The current position on febrile periods typically site three days for any one febrile period
but it is not clear how this number was determined. In our study, febrile periods were
usually one or two days, and subsequent relapses usually had shorter febrile periods, but
this was not always the case. In our study we used relapse data to not only look at the
expected number of febrile days a patient might experience for any one episode, but we
looked at how many days total an individual would be expected to experience fever
during the entire course of the disease. Our analyses found the expected number of febrile
episodes to be three and expected number of total febrile episodes for both infections’
types combined to be six days. This indicates that febrile periods might be shorter than
previously described but they might also be different depending on infection type. While
not statistically different, our analysis showed the average number of febrile episodes for
B. turicatae infections was two days less than its B. hermsii counterpart. Afebrile periods
have not been previously described but were included in this review to shed light on how
long the disease can endure. Afebrile periods, which averaged 7 days overall, and were
higher (albeit not statistically) in B. turicatae infections. One extreme case noted afebrile
periods accumulating 48 days resulting in relapsing fevers for months. There were
relatively wide ranges in each of these variables and were often different between
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infections, adding to the complications in characterizing the disease’s clinical
presentation.
Our results indicate that B. turicatae infections are clinically different from B.
hermsii infections and in many cases are associated with increased morbidity. Incubation
days for B. turicatae infections were longer, number of febrile episodes higher, and
reported higher proportions of various symptoms. Some of these differences may be due
to physicians not being aware that TBRF infections have two different causative agents.
This could lead to delayed diagnosis and in turn could cause a delay in treatment leading
to more febrile episodes, febrile days, and afebrile days.
TBRF treatment has evolved over the years with the advent of different antibiotics
but there seems to be little guidance in how these treatments are selected. To analyze
treatment effectiveness, we ran regressions to see if certain treatments resulted in better
outcomes. The current position in the medical community indicates that tetracycline is
the preferred treatment but there is little data to support why that is the case, even so,
tetracycline was used in our analyses as the referent group for this reason. Our data does
not support the hypothesis that other antibiotics or treatments, such as penicillin or
combination therapies might be more effective in reducing the risk of Jarisch –
Herxheimer reactions compared to tetracycline treatments alone but we note that due to a
small sample size, our ability to detect such a difference is limited. We cannot, at this
time, make any statistically sound inference on the association between treatment type
and risk of Jarisch – Herxheimer reaction. To analyze the number of febrile episodes we
used a Poisson regression. In this analysis, tetracycline results in lower incidence rate of
febrile episodes compared to other treatments, save for penicillin. Once again, these
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results are not statistically sound but both regressions provide the basis for the type of
analyses which can be used in the future on larger data sets to infer better and more
efficient treatment options for TBRF.
Consistent with prior assumptions, we found TBRF is primarily found in
traditionally healthy populations, occurring in summer months when vacationing to
remote cabins is most likely to occur. Sites which are older, have less regular upkeep, and
are uninhabited at times during the year present the most likely areas in which risk of
infection is higher.35 Temperature plays a catalytic role in the epidemiology of this
disease; hot weather encourages reservoir mammals to venture out of the tick’s habitat
while simultaneously attracting naïve humans into the habitat. During the fall and winter
months, rodent species turn to indoor or sheltered habitats to wait out the cold and
harshness of the outside conditions. Ornthidoros spp. ticks lie in wait to take blood meals
and ingest infected blood from rodent species which act as reservoirs and harbor the
Borellia bacteria. It is possible that Borellia hermsii and or Borellia turicate spirochetes
can be vertically transmitted during birth resulting in some ticks being born as vectors,
hosting the bacteria in their saliva.36 While rarely obsreced there is alos another route for
vector infection. Hyperparasitism between O. hermsi ticks has been observed which
resulted in previously uninfected O. hermsi ticks becoming infected with B. hermsii
spirochetes after being fed on by infected ticks.37 As the temperature increases during the
spring in summer, the rodents leave their nests to forage in the more hospitable climate
while outdoor enthusiasts move indoors to enjoy seasonal respites and become new hosts
to ticks. These seasonal movements are not just affected by temperature but also
reservoirs and people. Our review showed that ticks were recovered from infection sites
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only 21% of the time. This low number is partly due to the fact that not all sites were
investigated for tick infestations, but many which were still turned up no ticks. A special
report published in 2009 by Gaither, et.al provides a possible explanation for this.38
Gaither posits that tick movements are influenced by which host they are attempting to
feed on. Their research group originally began looking for ticks where one might assume
them to be found, in the nests of rodents, but soon found out that they were nowhere to be
seen. When widening their scope, they found black tar residues which turned out to be
blood as well as live and dead ticks in the cracks along window, near pictures close to
windows, crevices of walls, and near sleeping areas. Gaither mentions that finding soft
shelled ticks in these locations is unusual, so her team hypothesized that the ticks make
accommodations for host type and were moving within their area to increase the
likelihood of blood meals when humans were present. This hypothesis is not only
interesting because it gives researchers a better idea of where to locate these ticks but also
it shows that these, mostly nidicolous ticks, can become mobile and adapt to their hosts
making them far more resourceful than previously considered.
While most cases occurred in males there is no particular reason noted in this
review or any other literature source to indicate this is anything more than incidental. It
might be the case that areas where infection risk is higher might be visited more often by
males than females but there is no evidence of sex inherently increasing risk of infection.
Many of our cases took place in boys’ camps, caves, and forest cabins. It might be that
Ornthidoros spp. ticks inhabit areas frequented more my males compared to females.39
There is evidence to support this. We spoke to The National Speleological Society which
told us that among their 8000 members, the ratio of men to women was 2:1. This review
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also found no evidence to indicate that individuals might be more prone to infection
based on age, as infection was found in all age groups. Although mostly found in adults
and children, these groups most likely represent those coming into contact with these
nesting ticks due to their active lifestyles.
TBRF incidence is virtually impossible to measure due to lack of surveillance and
different reporting practices in 12 states that consider TBRF a notifiable condition. State
health department websites vary widely in which diseases have publicly available data
from year to year. TBRF is often left off the infectious disease surveillance reports for
years at time and there is no information on discerning infection type. The only major
reviews covering TBRF are an MMWR report published in 2015 with data on 504 cases
collected from 1990 - 2011 and the aforementioned article by Dworkin, et.al published in
1998 with information on 182 cases from 1980 – 1995.15,16 While their reviews have
similar findings to this one, one major difference is noted in respect to the occurrence of
Jarisch-Herxheimer reactions. Dworkin, et. al reported that Jarisch-Herxheimer reactions
occurred roughly 50% of the time in their 1998 review with 34 of the 66 cases which had
data on this outcome included in that review. Our review, which spans published reports
over a 100 - year span did not note nearly as many cases. There are a couple possible
solutions to resolve this discrepancy. One possibility is that the published reports did not
often have access to the complete details of the medical records which record which
described treatment and reaction. Another might be lack of awareness of the reaction led
to a lack of recognition when reviewing case files and misconstrued for the disease itself
instead of a response to treatment. By looking at medical records, Dworkin and his team
were able to identify Jarisch-Herxheimer reactions even when they weren’t explicitly
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reported due to the patients notes and symptom descriptions after treatment. It is possible
that disease management today is better than it was when Dworkin was collecting data
for his review 20 years ago but there is no formal treatment recommendation and despite
prevailing advice suggesting that tetracycline treatment is the best course for adults and
unpregnant women, our review noted cases of Jarisch-Herxhemier reactions in response
to that antibiotic as well as others. Regardless, the sample size from which this statistic
was derived is probably inflating how often this reaction is actually occurring but the
observations from both of these studies show why this outcome is of particular interest in
TBRF treatment.
This review highlights a number of reasons why TBRF should be a nationally
notifiable disease. Firstly, no major published works has summarized the current state of
the disease in the United States for over a decade. Secondly, the quality of data on the
topic and access to it are unreliable and leave much to be desired. California’s state health
department has arguably the best information publicly available on the disease but lacks
crucial information on treatment, number of relapses, and duration of disease. In other
states where TBRF is reportable, yearly incidence is not even reported in their
surveillance reports consistently, sometimes skipping years entirely. This leads to
inconsistent data, missing data, and a lack of not only public but professional awareness
which causes the disease to go mistreated and underdiagnosed. Even with standardized
reporting measures, universal reporting criteria, and increased awareness, this disease
will be challenging to address due to its multifaceted and unique clinical presentations,
similarities to viruses or other more common bacterial infections, and various incubation
periods.
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TBRF is a traveler’s disease. Most of our cases show that individuals or families
were vacationing or staying in remote wooded areas when they were infected. TBRF is
difficult to diagnose on its own but is more likely to be diagnosed in states where the
disease is endemic because physicians are more likely to look for it. For traveler’s which
return home to states where TBRF is not normally found and is not a reported disease, a
correct diagnosis might never be confirmed. The disease will usually run a self-limiting
course, but improper treatment and management will prolong patient suffering and
discomfort. To showcase this issue, consider the following evidence which was found in
during our review. TBRF was identified in travelers from Nebraska, Kansas, Florida, and
Texas in one report where all travelers had stayed in the same cabin located in the Rocky
Mountains in Colorado in 1995.40 While TBRF is found frequently in Texas it is not in
the other states mentioned. Upon returning home, the individuals from Texas were more
likely to be diagnosed correctly sooner. Without knowing what diseases are endemic in
certain areas, knowing which area a patient stayed in does little good. In another case
from 1967, a woman who had visited western states where TBRF is commonly found
returned to Boston and presented with multiple relapses of fever.41 This was originally
treated as a viral infection and the patient was discharged from the hospital when her
fever waned. When her fever recrudesced, she was readmitted and eventually received
tetracycline treatment until her fever and other symptoms reduced and was discharged
again. Had her doctor been aware of TBRF and the areas which it is endemic he or she
might have diagnosed TBRF sooner and saved the patient a return to the hospital.
This scenario where an outdoor enthusiast travels to an endemic area, becomes infected
while on vacation, incubates the infection during the trip, develops symptoms upon return
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to their home state, and has an extended course of disease due to a lack of physician
knowledge is not conjecture but shown to be likely common. The current state of
knowledge on the disease is such that physicians in non-endemic regions of the United
States are more likely to allow for greater periods of patient distress and continue to
contribute to underreporting of the disease.
TBRF is rarely fatal and over the course of a century, only two published case
reports resulted in mortality. The first, an elderly individual close to 70 years of age had a
heart attack while experiencing a febrile episode and subsequently died.42 Her symptom
profile reported one of the highest fevers collected in our review (105 degrees
Fahrenheit) and she also experienced hepatic enlargement which was one of the more
advanced, yet less common, symptoms. The second individual, a newborn infant, died
quickly after birth after acquiring a TBRF infection via transplacental means from the
mother.43 The only symptom reported were seizures and a low-grade fever before the
infant was found unresponsive. Both fatal cases had been identified as having a B.
hermsei infection. TBRF mortality is likely rare due to TBRF infections typically
occurring in younger, more robust individuals in good health. Despite the low mortality
rate, TBRF should still be considered especially dangerous to infant and elderly
populations and appropriate treatment is crucial to prevent death. Additionally, a higher
number of clinically advanced cases were seen. Meningitis cases, hepatosplenomegaly,
tachycardia, dyspnea and tachypnea and even jaundice. These are associated with much
worse outcomes and can be risk factors for disease later in life.
While not communicable from person to person, the disease has the potential to
be incredibly infectious on a large scale due to its short transmission time and clustered
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incidence. Three of our papers included in this review highlight this potential. On two
separate occasions, once in 1973, and again in 1990, outbreaks of TBRF occurred at the
Grand Canyon National Park in Arizona. In the first instance, 10 individuals were
infected between June and July of 1973. In almost the exact same location 17 years later
another 17 individuals were positively diagnosed with TBRF indicating that there are
hotspots for the tick vectors and their reservoirs where the pathogen maintains a stable
presence in the area. As recently as 2014, an outbreak occurred at an outdoor education
camp in Arizona where six confirmed cases and five probable cases of TBRF were
identified. The camps were often uninhabited save for the warmer months when campers
took up residence in older cabins.44–46 These examples are likely to become more
commonplace as accommodations and dwellings age and deteriorate, constructing
hospitable vector and mammalian reservoir habitats. The climate might begin to play
more of a factor as well. With warmer temperatures due to global warming, spring and
summer seasons are likely to see longer durations which will increase the window in
which infections are most likely to occur. Warmer climate might influence tick
movements as well. Although they are nesting ticks, the Ornthidoros species riding on
the backs of rodents or birds might find themselves in new areas if their hosts are able to
cover more ground for longer periods of time.47 If the ecological niche of these ticks
expands then a rise in incidence would be expected. Having a national reporting
recommendation would result in increased awareness for states which are currently not
experiencing TBRF infections but might begin to develop some. This would lead to
quicker recognition and better treatment plans for patients. The severity of the disease,
while varied, also presents potential for excruciating pain because of its cyclical progress.

33

The reoccurrence rate derived from the secondary analysis was 75%, meaning that
patients are very likely to experience more than one febrile episode with an unpredictable
accompaniment of debilitating symptoms as well as a high fever. This can hospitalize
patients for days, keeping them from work, accumulating considerable personal and
hospital economic burdens.
This review summarizes a large period of time on published data and gives an
idea as to the scope of not only the disease itself but the difficulty in studying and treating
it. The major limitations of this study are the relatively small sample size, missing data,
and data quality. Although, this being a review, is a reflection of the quality and quantity
of published data available and a reflection of the overall limitations in studying the
disease. This review, while expansive in both years, as well as the amount of information
included does have a number of limitations. The first of which is the data collection
process. While other reviews had requested state specific data from health departments
and accompanying medical records, our review was conducted using only published
literature. The accuracy of our data is dependent on the various methodologies utilized in
the published reports we used to construct our data set and often these reports shared
varying degrees of information, some detailed and ordinal, others less so. In places where
exact data was not available, best estimates were used for analysis. Some of the years
listed for reviews gave a range but did not associate their cases with precise years, in this
instance we chose to take the midpoint of the range as the year of incidence. Overlapping
cases is a possible issue. While we diligently reviewed the papers chosen so as not to
include duplicate data there is still the possibility that some of these cases might have
been reported on in multiple papers. With large sample sizes taken from a range of years
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it is difficult to tell if those cases overlap with any on other reports on cases in those areas
within those years.
Generalizability is another possible issue. Due to the unique methodology
presented here, making comparisons between previous works must be taken with some
considerations in mind on how data was collected in those papers vs. this one.
Comparisons within this paper should also be thought of in the same light given the
added criteria for inclusion in the secondary analysis. This difference can help explain
some possible notable discrepancies in the data presented here.
Despite its limitations, we note that this review has a number of strengths. This is
the only review, to our knowledge, that has reported on TBRF and analyzed differences
in clinical presentation and prognosis by infection type. Another strength of this study is
its sample size and geographic range, including data on 14 states. This review also
highlights trends and updates the medical and epidemiological community with the
largest study on the topic in many years. This study was able to show that there are
differences in clinical presentation of this disease based on infection type and these
differences are worth further exploring to standardize treatment protocols and diagnosis,
lower morbidity and mortality, and help preventions efforts by targeting endemic areas
and hotspots as well as increase the public awareness of the disease. With increased
awareness and standardized reporting measures, physicians and public health
professionals can more readily identify a relapsing fever infection and treat it. Increased
treatment not only leads to better health outcomes and reduced morbidity for patients but
also increases the amount of data available on treatment which can improve treatment
practices and help develop personalized treatment plans.
35
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This review can be seen as a template for the type of information and reporting
which would be useful in the NNDSS. Data on infection type is crucial to understanding
how and where the pathogen spreads and how this results in different clinical
presentations. Furthermore, understanding which treatments work best requires precise
data on which antibiotics were used, their dosage, and treatment course with an emphasis
on lowering the number of relapses and incidence of Jarisch-Herxheimer reactions. In
addition, modeling data can be improved by inclusion of more covariates. In this review,
data on only sex and age was available but race, body mass index, socioeconomic status,
etc. might be important for developing reliable models. In conclusion, TBRF should be a
nationally notifiable disease because it is vastly underreported, lacks awareness in the
medical community, especially in non-endemic states, is reported infrequently and
inconsistently which results in poor data pertaining to the disease and its pathogen, and
because best treatment practices which limit morbidity and other unfavorable outcomes is
impossible to determine with the current data available. An inclusion on the list of
nationally notifiable conditions will push TBRF to the forefront of clinician concerns,
create better data quality on this disease, and limit future infections and outbreaks while
lowering morbidity and mortality for those who are infected.
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